BACTBS Stock Overview
A medical device company, provides infection prevention solutions in orthopedics, urology, intravascular/critical care, dental, and wound care therapeutic areas in the United States, Sweden, Malaysia, India, Bangladesh, Indonesia, the Kingdom of Saudi Arabia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Bactiguard Holding AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 128.60 |
| 52 Week High | SEK 163.80 |
| 52 Week Low | SEK 83.70 |
| Beta | -0.12 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | 51.65% |
| 5 Year Change | 489.91% |
| Change since IPO | 290.88% |
Recent News & Updates
Recent updates
Shareholder Returns
| BACTBS | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | -2.2% | -0.5% |
| 1Y | n/a | 6.5% | 7.9% |
Return vs Industry: Insufficient data to determine how BACTBS performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how BACTBS performed against the UK Market.
Price Volatility
| BACTBS volatility | |
|---|---|
| BACTBS Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.9% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 9.3% |
| 10% least volatile stocks in GB Market | 2.5% |
Stable Share Price: BACTBS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BACTBS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 216 | Anders Goransson | www.bactiguard.com |
Bactiguard Holding AB (publ), a medical device company, engages in the development and supply of infection prevention solutions in Sweden and internationally. Its infection prevention solutions reduce the risk of healthcare associated infections and the use of antibiotics. The company’s products portfolio of urinary catheters, endotracheal tubes, and central venous catheters reduces the risk of infections in the urinary tract, the respiratory tract, and the bloodstream.
Bactiguard Holding AB (publ) Fundamentals Summary
| BACTBS fundamental statistics | |
|---|---|
| Market cap | SEK 4.05b |
| Earnings (TTM) | -SEK 64.10m |
| Revenue (TTM) | SEK 212.12m |
19.1x
P/S Ratio-63.2x
P/E RatioIs BACTBS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BACTBS income statement (TTM) | |
|---|---|
| Revenue | SEK 212.12m |
| Cost of Revenue | SEK 44.85m |
| Gross Profit | SEK 167.27m |
| Other Expenses | SEK 231.37m |
| Earnings | -SEK 64.10m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
Apr 05, 2023
| Earnings per share (EPS) | -1.83 |
| Gross Margin | 78.86% |
| Net Profit Margin | -30.22% |
| Debt/Equity Ratio | 35.1% |
How did BACTBS perform over the long term?
See historical performance and comparison